Filters

Jeffrey L Saver

Showing results (1-10 of 713) with videos related to

Pageof 72
Sort By:
Stroke|August 16, 2008
Proposal for a universal definition of cerebral infarctionJeffrey L Saver
Stroke|March 31, 2007
Clinical impact of NXY-059 demonstrated in the SAINT I trial: derivation of number needed to treat for benefit over entire range of functional disabilityJeffrey L Saver
Reviews in Neurological Diseases|April 23, 2010
Target brain: neuroprotection and neurorestoration in ischemic strokeJeffrey L Saver
Cardiology Clinics|September 25, 2024
Patent Foramen Ovale-Associated Stroke: A Neurologist's PerspectiveJeffrey L Saver
Pharmacotherapy|June 26, 2010
Targeting the brain: neuroprotection and neurorestoration in ischemic strokeJeffrey L Saver
Stroke|October 6, 2007
Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trialsJeffrey L Saver
Stroke|December 13, 2005
Time is brain--quantifiedJeffrey L Saver
Stroke|July 21, 2007
Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harmJeffrey L Saver
Archives of Neurology|July 21, 2004
Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute strokeJeffrey L Saver
Stroke|July 2, 2011
Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devicesJeffrey L Saver
Pageof 72

Showing results (1-10 of 713) with videos related to

Sort By:
Pageof 72
Stroke|August 16, 2008
Proposal for a universal definition of cerebral infarctionJeffrey L Saver
Stroke|March 31, 2007
Clinical impact of NXY-059 demonstrated in the SAINT I trial: derivation of number needed to treat for benefit over entire range of functional disabilityJeffrey L Saver
Reviews in Neurological Diseases|April 23, 2010
Target brain: neuroprotection and neurorestoration in ischemic strokeJeffrey L Saver
Cardiology Clinics|September 25, 2024
Patent Foramen Ovale-Associated Stroke: A Neurologist's PerspectiveJeffrey L Saver
Pharmacotherapy|June 26, 2010
Targeting the brain: neuroprotection and neurorestoration in ischemic strokeJeffrey L Saver
Stroke|October 6, 2007
Novel end point analytic techniques and interpreting shifts across the entire range of outcome scales in acute stroke trialsJeffrey L Saver
Stroke|December 13, 2005
Time is brain--quantifiedJeffrey L Saver
Stroke|July 21, 2007
Hemorrhage after thrombolytic therapy for stroke: the clinically relevant number needed to harmJeffrey L Saver
Archives of Neurology|July 21, 2004
Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute strokeJeffrey L Saver
Stroke|July 2, 2011
Optimal end points for acute stroke therapy trials: best ways to measure treatment effects of drugs and devicesJeffrey L Saver
Pageof 72
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us